FDAnews Device Daily Bulletin
Medical Devices / Commercial Operations

Axonics Names New Director

March 5, 2019
A A

Axonics, a developer of novel implantable sacral neuromodulation devices for the treatment of urinary and bowel dysfunction, has named Michael Carrel to its board of directors.

Carrel has served as president and CEO of AtriCure, a developer of treatments for atrial fibrillation and other related conditions, since 2012.

He was previously president and CEO of Vital Images, a medical imaging software company, and Zamba, a technology company. He is currently a board member of the Medical Device Manufacturers Association.

View today's stories